Bilateral maculopathy associated with sertraline. (December 2014)

• Record Type: Journal Article
• Authors: Ewe, Shaun YP; Abell, Robin G; Vote, Brendan J
• Is Part Of: Australasian psychiatry. Volume 22:Number 6(2014:Dec.)
• Page Start: 573
• Page End: 575
• Publication Date: 2014-12
• Subjects: sertraline -- selective serotonin reuptake inhibitor -- drug-induced -- ocular toxicity -- maculopathy; Psychiatry -- Australasia -- Periodicals; Psychiatry -- Periodicals; 616.89005
• DOI: 10.1177/1039856214556327
• Languages: English
• ISSNs: 1039-8562

Abstract

Objective: We report a rare case of bilateral maculopathy that developed with the initiation of sertraline. Methods: We conducted a case report and review of the literature. Results: A 23-year-old man rapidly developed maculopathy with associated visual blurring after the initiation of sertraline. Treatment was ceased with the patient subsequently reporting mild improvement in visual symptoms. Conclusions: Maculopathy associated with sertraline use has yet to be established and recognized as an adverse side effect. With only one previous reported case in the literature, this condition requires further awareness.